Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000004.xml
Aktuelle Neurologie 2006; 33(9): 509-524
DOI: 10.1055/s-2005-915406
DOI: 10.1055/s-2005-915406
Fort- und Weiterbildung
© Georg Thieme Verlag KG Stuttgart · New York
Vaskuläre Demenz und Morbus Alzheimer: Abgrenzung und Überlappung
Vascular Dementia and Alzheimer Disease: Overlap and DifferentiationFurther Information
Publication History
Publication Date:
02 November 2006 (online)

Weiterbildungsziele
In diesem Beitrag sollen folgende Weiterbildungsziele vermittelt werden:
Unterschiedliche Formen vaskulär bedingter Demenzsyndrome Klinische, neuropsychologische und strukturelle Abgrenzung vaskulärer Demenzen gegenüber der Alzheimer-Demenz Diagnose der degenerativ/vaskulären Mischdemenz Befunde und Hypothesen zur vaskulären Komponente der Alzheimer-Demenz
Literatur
- 1 Roman G C, Tatemichi T K, Erkinjuntti T. et al . Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology. 1993; 43 250-260
- 2 Barker W E, Luis C A, Kashuba A. et al . Relative frequencies of Alzheimer's disease, Lewy body, vascular and frontotemporal dementia, and hippocampal sclerosis in the State of Florida Brain Bank. Alzheimer Disease and Associated Disorders. 2002; 16 203-212
- 3 Lobo A, Launer L J, Fratiglioni L. et al . Prevalence of dementia and major subtypes in Europe: A collaborative study of population-based cohorts. Neurology. 2000; 54 (suppl 5) S4-S9
- 4 Erkinjuntti T, Gauthier S. Vascular Cognitive Impairment. London; Martin Dunitz 2002
-
5 Haberl R L, Schreiber A K.
Vaskuläre Demenzen. In: Wallesch CW, Förstl H (Hrsg) Demenzen. Stuttgart; Thieme 2005: 221-229 - 6 Schmidtke K. Demenzen. Diagnostik und Behandlung in der Facharztpraxis und Gedächtnissprechstunde. Kapitel 8: Demenz bei vaskulären Schädigungen. Stuttgart; Kohlhammer 2006: 208-232
- 7 O'Brian J, Reisberg B, Erkinjuntti T. IPA Expert Consensus Conference „Vascular Burden of the Brain: New Therapeutic Directions”. International Psychogeriatrics. 2003; 15, Suppl 1
-
8 Hamann G, Böhm M, Busse O. et al .
Vaskuläre Demenzen. In: Diener HC, Hacke W (Hrsg) Leitlinien für Diagnostik und Therapie in der Neurologie. 3. Auflage. Stuttgart; Thieme 2005: 130-141 - 9 White L, Petrovitch H, Hardman J. et al . Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants. Annals of the New York Academy of Science. 2002; 977 9-23
- 10 Kövari E, Gold G, Herrmann F R. et al . Cortical microinfarcts and demyelination significantly affect cognition in brain aging. Stroke. 2004; 35 410-414
- 11 Moretti R, Torre P, Antonello R. et al . Neuropsychological evaluation of late-onset post-radiotherapy encephalopathy: a comparison with vascular dementia. Journal of the Neurological Sciences. 2005; 229 - 230 195-200
- 12 Baezner H, Hennerici M. From trepidant abasia to motor networt failure - gait disorders as a consequence of subcorctical vascular encephalopathy (SVE). Review of historical and contemporary concepts. Journal of the Neurological Sciences. 2005; 229 - 230 81-88
- 13 Schmidt R, Schmidt H, Lapeller P, Fazekas F. Slow progression of white-matter changes. International Psychogeriatrics. 2003; 15 (Suppl 1) 173-176
- 14 Schmidtke K, Hüll M. Cerebral Small Vessel Disease: how does it progress?. Journal of the Neurological Sciences. 2005; 229 - 230 13-20
- 15 Reed B R, Eberling J L, Mungas D. et al . Effects of white matter lesions and lacunes on cortical function. Arch Neurol. 2002; 61 1545-1550
- 16 Schmidtke K, Hüll M. Neuropsychological differentiation of Small Vessel Disease, Alzheimer's Disease and Mixed Dementia. Journal of the Neurological Sciences. 2002; 9 419-429
- 17 Satzger W, Hampel H, Padberg F. et al . Zur praktischen Anwendung der CERAD-Testbatterie als neuropsychologisches Defizitscreening. Nervenarzt. 2001; 72 196-203
- 18 Shulman K I. Clock-drawing: is it the ideal cognitive screening test?. Int J Geriatr Psychiatry. 2000; 15 548-561
- 19 Oswald W D, Fleischmann U M. Psychometrics in aging and dementia: advances in geropsychological assessments. Arch Gerontol Geriatr. 1985; 4 299-309
- 20 Pantoni L, Simoni M. Pathophysiology of cerebral small vessels in vascular cognitive impairment. International Psychogeriatrics. 2003; 15, Suppl 1 59-65
- 21 Moody D M, Bell M A, Challa V R. The corpus callosum, a unique white-matter tract: anatomic features that may explain sparing in Binswanger disease and resistance to flow of fluid masses. Am J Neuroradiol. 1988; 9 1051-1059
- 22 Straaten E C van, Scheltens P, Knol D L. et al . Operational definitions for the NINDS-AIREN criteria for vascular dementia. An interobserver study. Stroke. 2003; 34 1907-1912
- 23 Jobst K A, Barnetson L P, Shepstone B J. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging. Int Psychogeriatr. 1998; 10 271-302
- 24 Dougall N J, Bruggink S, Ebmeier K P. Systematic review of the diagnostic accuracy of 99mTc-HMPAO-SPECT in dementia. Am J Geriatr Psychiatry. 2004; 12 554-570
- 25 Wolf H, Ecke G M, Bettin S. et al . Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 2000; 15 803-812
- 26 Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease?. Journal of the Neurological Sciences. 2005; 229 - 230 151-155
- 27 Benson D F, Cummings J L. Angular gyrus syndrome imitating Alzheimer's Disease. Archives of Neurology. 1982; 39 616-620
- 28 Torre J C de la. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurology. 2004; 3 184-190
- 29 Hentschel F, Supprian T, Frölich L. Alzheimer-Demenz versus vaskuläre Demenz - Dichotomie oder Interaktion?. Fortschritte der Neurologie Psychiatrie. 2005; 73 317-326
- 30 Jellinger K, Attems J. Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study. Acta Neuropathologica. 2003; 105 14-17
- 31 Honig L S, Tang M X, Albert S. et al . Stroke and the risk of Alzheimer disease. Archives of Neurology. 2003; 60 1707-1712
- 32 Snowdon D A, Grenier L H, Mortimer J A. et al . Brain infarction and the clinical expression of Alzheimer disease: The Nun Study. JAMA. 1997; 227 813-817
- 33 DeCarli C. Vascular factors in dementia: an overview. Journal of the Neurological Sciences. 2004; 226 19-23
- 34 Sjögren M, Blennow K. The link between cholesterol and Alzheimer's disease. World Journal of Biological Psychiatry. 2005; 6 85-97
- 35 Luchsinger J A, Mayeux R. Cardiovascular risk factors and Alzheimer's disease. Current Atherosclerosis Reports. 2004; 6 261-266
- 36 Seshadri S, Beiser A, Selhub J. et al . Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. New England Journal of Medicine. 2002; 346 476-483
- 37 Skoog I, Lernfeldt B, Landahl S. et al . 15-year longitudinal study of blood pressure and dementia. Lancet. 1996; 347 1141-1145
- 38 Iadecola C, Gorelick P B. Converging pathogenetic mechanisms in vascular and neurodegenerative dementia. Stroke. 2003; 34 335-337
- 39 Schmidt R, Schmidt H, Kapeller P. et al . The natural course of MRI white matter hyperintensities. Journal of the Neurological Sciences. 2002; 203 - 204 253-257
- 40 Sabri O, Hellwig D, Schreckenberger M. et al . One-year follow-up of neuropsychology, MRI, rCBF and glucose metabolism (rMRGlu) in cerebral microangiopathy. Nuklearmedizin. 2000; 39 43-49
- 41 Groot J C De, Leeuw F E De, Oudkerk M. et al . Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann Neurol. 2002; 52 335-341
- 42 Bracco L, Campani D, Baratti E. et al . Relation between MRI features and dementia in cerebrovascular disease patients with leukoaraiosis: a longitudinal study. J Neurol Sci. 1993; 120 131-136
- 43 Tian J, Shi J, Mann D M. Cerebral amyloid angiopathy and dementia. Panminerva Medica. 2004; 46 253-264
- 44 Jellinger K, Attems J. Prevalence and pathogenetic role of cerebrovascular lesions in Alzheimer disease. Journal of the Neurological Sciences. 2005; 229 - 230 37-41
- 45 Nicoll J AR, Yamada M, Frackowiak J. et al . Cerebral amyloid angiopathy plays a direct role in the pathogenesis of Alzheimer's disease. Neurobiology of Aging. 2004; 25 589-597
- 46 Garde E, Mortensen E L, Krabbe K. et al . Relation between age-related decline in intelligence and cerebral white-matter hyperintensities in healthy octogenarians: a longitudinal study. Lancet. 2000; 356 628-634
- 47 Sabri O, Ringelstein E B, Hellwig D. et al . Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke. 1999; 30 556-566
Prof. Dr. K. Schmidtke
ZGGF
Lehener Straße 88
79106 Freiburg
Email: klaus.schmidtke@uniklinik-freiburg.de